Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

PBE vs SHPAX overlap: 26% of top holdings shared

Bottom line

How much do PBE and SHPAX overlap?

26% of their top holdings overlap by weight. 7 securities appear in both funds' top 25, making up 29.9% of PBE's assets and 29.9% of SHPAX's. They are substantially different portfolios, so owning both adds real diversification.

Updated Nov 22, 2026

Overlap at a glance

PBESHPAX
Weight overlap (top 25)26%
Shared holdings7
Weight in shared holdings29.9%29.9%
Total positions3329
Expense ratio0.59%3%
Holdings as ofJul 31, 2026May 31, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Holdings PBE and SHPAX have in common

Holding% of PBE% of SHPAXOverlap
Regeneron Pharmaceuticals, Inc.5.47%3.93%3.93%
Amgen Inc.5.22%5.04%5.04%
Vertex Pharmaceuticals Inc.4.99%3.36%3.36%
Gilead Sciences, Inc.4.43%3.94%3.94%
United Therapeutics Corp.4.08%6.17%4.08%
Incyte Corp.3.06%2.89%2.89%
Exelixis, Inc.2.64%4.55%2.64%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in PBE

  1. Invesco Private Prime Fund — 12.89%
  2. CareDx, Inc. — 5.04%
  3. Invesco Private Government Fund — 4.97%
  4. Royalty Pharma PLC — 4.94%
  5. Biogen Inc. — 4.79%
  6. Bio-Techne Corp. — 3.73%
  7. Illumina, Inc. — 3.51%
  8. Protagonist Therapeutics, Inc. — 3.40%
  9. Vericel Corp. — 3.27%
  10. Alnylam Pharmaceuticals, Inc. — 3.17%
  11. Repligen Corp. — 3.04%
  12. Acadia Pharmaceuticals Inc. — 3.02%
  13. Halozyme Therapeutics, Inc. — 2.98%
  14. Qiagen N.V. — 2.89%
  15. BioMarin Pharmaceutical Inc. — 2.82%

Only in SHPAX

  1. Cardinal Health Inc — 6.44%
  2. Jazz Pharmaceuticals Plc — 6.19%
  3. Mckesson Corp — 4.90%
  4. Lantheus Holdings Inc — 4.64%
  5. Novartis Ag — 4.50%
  6. Cencora Inc — 4.33%
  7. Johnson & Johnson — 3.91%
  8. National Healthcare Corp — 3.72%
  9. Merck & Company Inc — 3.63%
  10. Cigna Group (the) — 3.63%
  11. Medpace Holdings Inc — 3.37%
  12. Intuitive Surgical Inc — 3.14%
  13. Bristol-myers Squibb Company — 3.07%
  14. Stryker Corp — 2.40%
  15. Medtronic Plc — 2.20%

Asset mix

Asset typePBESHPAX
Stocks100.1%99.0%
Cash & short-term funds17.9%1.6%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Country mix

CountryPBESHPAX
US108.6%86.1%
IE—8.4%
GB4.9%—
CH—4.5%
NL2.9%—
KY1.6%—
DK—1.6%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Check another pair

FAQ

How much do PBE and SHPAX overlap?
About 26% by weight. 7 securities appear in both funds' top 25 holdings; they make up 29.9% of PBE's assets and 29.9% of SHPAX's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do PBE and SHPAX have in common?
The largest shared holdings are Amgen Inc., United Therapeutics Corp., Gilead Sciences, Inc., Regeneron Pharmaceuticals, Inc., Vertex Pharmaceuticals Inc..
Should I own both PBE and SHPAX?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, PBE or SHPAX?
PBE is broader, with 33 positions versus 29 for SHPAX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.